Venture Capital Predicts the Future
Venture capitalists discuss healthcare investment trends, predicting breakthroughs in digital health, biopharmaceuticals, and home care while addressing industry challenges and future opportunities.
Quantum Computing Technology for Material Science
Explore quantum computing's transformative impact on material science, from pharmaceuticals to semiconductors and photonics. Gain insights into its power and diverse applications.
Do Chemformers Dream of Organic Matter? Evaluating Transformer Models for Synthesis Prediction
Explore transformer models for synthesis prediction in drug discovery, including challenges, comparisons, and performance in product and retrosynthesis prediction for pharmaceutical applications.
Industrializing Machine Learning Workflows in Drug Discovery
Discover how machine learning workflows accelerate drug discovery through automated predictive modeling, data management, and cloud computing for evaluating compound properties and safety.
AI-Driven Drug Repurposing: Multi-Agent Approach in Bioinformatics
Explore how three AI agents work together to revolutionize drug discovery through molecular binding prediction, knowledge graph analysis, and scientific literature mining for faster medical breakthroughs.
Empowering Executives to Embrace Quantum Computing
Explore quantum computing's potential, applications, and executive strategies for leveraging this transformative technology in various industries.
Small-Molecule Binding to Intrinsically Disordered Proteins - Characterization and Implications for Drug Design
Explore integrative methods for characterizing disordered proteins, focusing on amyloid-β and its interaction with small molecules to prevent toxic aggregation in Alzheimer's disease.
Pre-training Molecular Graph Representation with 3D Geometry
Explore molecular graph representation learning, leveraging 3D geometry for enhanced drug and material discovery through self-supervised learning and the GraphMVP framework.
Machine Learning-Driven Phenotyping Platform for Rapid In Vivo Target Validation and Precision Medicine
Develop a zebrafish phenotyping platform using 3D-printed mounts and computer vision for drug discovery, enabling rapid gene-to-phenotype analysis and accelerating clinical translation.
PolypharmDB: Quickly Identifying Repurposed Drug Candidates for COVID-19
Explore PolypharmDB, a deep learning-based resource for identifying repurposed drug candidates for COVID-19. Learn about accelerated drug discovery methods using existing clinical data.
Can Data-Centric AI Help Us Develop Better Drugs?
Explore how machine learning and high-quality data can revolutionize drug development, predicting outcomes and designing safer, more effective therapies faster and at lower costs.
Custom CRISPR Solutions for High-Throughput Workflows in Drug Discovery
Discover high-throughput CRISPR genome editing techniques for research and drug discovery, focusing on arrayed synthetic guide RNA libraries and custom solutions.
How Will Quantum Computing Affect Our Everyday Lives in the Future?
Explore the potential impact of quantum computing on daily life with Xanadu's CEO and an Economist editor at Collision 2023.
A Universal Programmable Gaussian Boson Sampler for Drug Discovery
Explore a cutting-edge quantum computing approach for accelerating drug discovery using Gaussian boson sampling, presented by Shang Yu from Imperial College London.
Overview of Machine Learning Approaches at GSK.ai
Explore machine learning approaches at GSK.ai, focusing on innovative techniques and applications in pharmaceutical research and development.
High Performance Computing Workloads on Google Cloud
Explore Google Cloud's HPC solutions for critical workloads, infrastructure advancements, and customer deployments in computational sciences and AI/ML.
Unleashing the Power of Quantum Computing - Theory and Practical Applications
Explore quantum computing fundamentals, algorithms, applications, and future prospects. Gain insights into hardware, software, and practical implementations of this revolutionary technology.
Structure-Aware Protein Self-Supervised Learning
Explore structure-aware protein self-supervised learning, combining GNN models with protein language models to enhance structural information capture for improved downstream task performance.
AI-Aided Design of Novel Inhibitors Against SARS-CoV-2
Explore AI-driven drug design for SARS-CoV-2, focusing on 3CLpro inhibitors. Learn about deep Q-learning networks, fragment-based design, and structure-based optimization for developing potential lead compounds.
Cancer Drug Discovery AI Agentic Workflow R&D
Explore AI agentic workflows for cancer drug discovery, leveraging advanced automation techniques to enhance compound lead generation and streamline the R&D process.
Speed-ups for State-of-the-Art Generative AI Drug Discovery Applications
Explore cutting-edge generative AI techniques for drug discovery, including VAEs, Hugging Face pipelines, and LLM comparisons. Learn to accelerate inference times using C++ and cloud platforms.